Saudi Arabia GDN Press Release 2019 New Member Update
Al Borg Laboratories Welcomes New Members to the Global Diagnostics Network (GDN)
Two new companies join the GDN, expanding this novel worldwide network of leading diagnostics service providers
With 9 members across all continents, the GDN has a presence in countries covering two-thirds of the world’s population, and over 90% of the global pharmaceutical market
Jeddah, June 30, 2019 – Al Borg Medical Laboratories, the region’s leading provider of diagnostic laboratory services, announced today the expansion of the Global Diagnostics Network (GDN), a strategic working group of major diagnostic laboratories collaborating to generate enhanced diagnostics insights to improve the delivery of global healthcare. LSI Medience,and Strand Life Sciences join Al Borg and the charter GDN members – Quest Diagnostics, Dasa, GC Labs, KingMed Diagnostics, Healius, SYNLAB.
“We welcome these two new GDN members and are eager to continue acceleration of the network’s programs that will reach patients in every part of the world,” said Dr Fawaz Al Bishri, Chairman of Al Borg Medical Laboratories. “Since launching in October 2018, the GDN has made great strides in increasing access to diagnostic technology innovation, and in building the largest global launch platform for rapid deployment of companion diagnostics.” technologies.
Collectively, this worldwide community of 9 leading healthcare companies has a presence in countries with two-thirds of the world’s population, and over 90% of the global pharmaceutical market.
“Global access to companion diagnostics through the GDN will enable faster, higher quality, and consistent delivery of precision medicine to healthcare systems and patients around the world,” commented Dr. Hisham Shams, Chief Medical Officer at Al Borg. “The GDN also provides us with the ability to develop a rapid and proactive responses to potentially pandemic emerging pathogens and to better understand how to interpret genetic and other lab testing results based on geography and ethnicity – a significant unmet need in our industry. We are excited that the GDN is expanding and eager to recognize its potential.”
About the Global Diagnostics Network
The Global Diagnostics Network (GDN) is a strategic working group of diagnostic laboratories across major regions, each committed to unleashing and sharing local innovation to increase global access to diagnostic science, information, and services.
The GDN enables sharing of best practices among the top scientific minds internationally, which will accelerate the development and delivery of advanced diagnostics and ultimately generate enhanced diagnostic insights to improve the delivery of global healthcare. GDN initiatives benefit patients, healthcare providers, referring practitioners, pharmaceutical innovators, government agencies, non-governmental organizations (NGOs), and academic institutions.
For more information about the GDN, please visit www.globaldiagnosticsnetwork.com
About Al Borg Laboratories
Al Borg Medical Laboratories was established in 1999 as a 100% Saudi Limited Liability Company in Jeddah; the heart of the Western Province to provide a wide range of clinical and diagnostic tests for its clients. Al Borg Medical Laboratories now has become the largest chain of private laboratories in the Gulf Region with more than 60 laboratories covering the Kingdom of Saudi Arabia, United Arab Emirates, Qatar, Oman, Bahrain, Kuwait, Sudan and Ethiopia.
Our company is not limited to serving walk-in clients but also has a large network of commercial and medical governmental hospitals, clinics, Insurance, banks, airlines, and international pharmaceutical companies. Striving to bridge the gap between the continuous advancements and breakthrough of the lab testing industry to the end consumer in each and every district. Al Borg Laboratories exists by offering accessibility, reliability and convenience.